BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 27182762)

  • 1. Insulin Resistance and Diabetes Mellitus in Contemporary Cardiac Rehabilitation.
    Khadanga S; Savage PD; Ades PA
    J Cardiopulm Rehabil Prev; 2016; 36(5):331-8. PubMed ID: 27182762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiometabolic responses to cardiac rehabilitation in people with and without diabetes.
    Laddu DR; Ozemek C; Hauer TL; Rouleau CR; Campbell TS; Wilton SB; Aggarwal S; Austford L; Arena R
    Int J Cardiol; 2020 Feb; 301():156-162. PubMed ID: 31806276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus.
    Kautzky-Willer A; Kamyar MR; Gerhat D; Handisurya A; Stemer G; Hudson S; Luger A; Lemmens-Gruber R
    Gend Med; 2010 Dec; 7(6):571-83. PubMed ID: 21195357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome severity is significantly associated with future coronary heart disease in Type 2 diabetes.
    Gurka MJ; Guo Y; Filipp SL; DeBoer MD
    Cardiovasc Diabetol; 2018 Jan; 17(1):17. PubMed ID: 29351794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of clinical and biochemical variables in type 2 diabetes mellitus patients and their first-degree relatives with metabolic syndrome in Benin City, Nigeria: A cross sectional case controlled study.
    Ogedengbe S; Ezeani IU; Aihanuwa E
    Endocr Regul; 2016 Jan; 50(1):32-40. PubMed ID: 27560635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Weight, the metabolic syndrome, and coronary heart disease in type 2 diabetes: associations among a national French sample of adults with diabetes-the ENTRED study.
    Hillier TA; Fosse S; Balkau B; Simon D; Eschwège E; Fagot-Campagna A
    J Cardiometab Syndr; 2006; 1(5):318-25. PubMed ID: 17679788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential benefits of weight loss in coronary heart disease.
    Ades PA; Savage PD
    Prog Cardiovasc Dis; 2014; 56(4):448-56. PubMed ID: 24438737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetes severity, metabolic syndrome, and the risk of erectile dysfunction.
    Weinberg AE; Eisenberg M; Patel CJ; Chertow GM; Leppert JT
    J Sex Med; 2013 Dec; 10(12):3102-9. PubMed ID: 24010555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of metabolic syndrome in cardiac rehabilitation/secondary prevention programs.
    Savage PD; Banzer JA; Balady GJ; Ades PA
    Am Heart J; 2005 Apr; 149(4):627-31. PubMed ID: 15990744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular disease in Japanese elderly with type 2 diabetes mellitus.
    Sakurai T; Iimuro S; Araki A; Umegaki H; Ohashi Y; Yokono K; Ito H
    Gerontology; 2010; 56(2):141-9. PubMed ID: 19828932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of low serum testosterone levels among men with type 2 diabetes mellitus attending two outpatient diabetes clinics in KwaZulu-Natal Province, South Africa.
    Paruk IM; Pirie FJ; Nkwanyana NM; Motala AA
    S Afr Med J; 2019 Nov; 109(12):963-970. PubMed ID: 31865960
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The normal-weight type 2 diabetes phenotype revisited.
    Hermans MP; Amoussou-Guenou KD; Bouenizabila E; Sadikot SS; Ahn SA; Rousseau MF
    Diabetes Metab Syndr; 2016; 10(2 Suppl 1):S82-8. PubMed ID: 26960924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is serum C-reactive protein concentration correlated with HbA1c and insulin resistance in Type 2 diabetic men with or without coronary heart disease?
    Bahceci M; Tuzcu A; Ogun C; Canoruc N; Iltimur K; Aslan C
    J Endocrinol Invest; 2005 Feb; 28(2):145-50. PubMed ID: 15887860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in physical fitness predict improvements in modifiable cardiovascular risk factors independently of body weight loss in subjects with type 2 diabetes participating in the Italian Diabetes and Exercise Study (IDES).
    Balducci S; Zanuso S; Cardelli P; Salvi L; Mazzitelli G; Bazuro A; Iacobini C; Nicolucci A; Pugliese G;
    Diabetes Care; 2012 Jun; 35(6):1347-54. PubMed ID: 22399699
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-calorie-expenditure exercise: a new approach to cardiac rehabilitation for overweight coronary patients.
    Ades PA; Savage PD; Toth MJ; Harvey-Berino J; Schneider DJ; Bunn JY; Audelin MC; Ludlow M
    Circulation; 2009 May; 119(20):2671-8. PubMed ID: 19433757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the Role of Serum 25-Hydroxy Vitamin D Level on Coronary Heart Disease Risk With Stratification Among Patients With Type 2 Diabetes Mellitus.
    Bener A; Al-Hamaq AOAA; Zughaier SM; Öztürk M; Ömer A
    Angiology; 2021 Jan; 72(1):86-92. PubMed ID: 32840113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The magnitude of obesity and metabolic syndrome among diabetic chronic kidney disease population: A nationwide study.
    Kittiskulnam P; Thokanit NS; Katavetin P; Susanthitaphong P; Srisawat N; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
    PLoS One; 2018; 13(5):e0196332. PubMed ID: 29742114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of simple clinical parameters to predict insulin resistance among newly diagnosed patients with type 2 diabetes in limited resource settings.
    Wasana KGP; Attanayake AP; Weerarathna TP; Jayatilaka KAPW
    PLoS One; 2021; 16(3):e0248469. PubMed ID: 33788827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Triglyceride glucose index for the detection of asymptomatic coronary artery stenosis in patients with type 2 diabetes.
    Thai PV; Tien HA; Van Minh H; Valensi P
    Cardiovasc Diabetol; 2020 Sep; 19(1):137. PubMed ID: 32919465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sleeping disturbances and predictor risk factors among type 2 diabetic mellitus patients.
    Bener A; Al-Hamaq AOAA; Agan AF; Öztürk M; Ömer A
    Ann Afr Med; 2020; 19(4):230-236. PubMed ID: 33243945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.